FDA issues guidance on DSCSA that affect pharmacies

Last week, the FDA issued three pieces of guidance for pharmacies. The first, entitled Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act, updated and finalized a June 2021 draft guidance. In this guidance, FDA emphasized that pharmacies (known as “dispensers” in the DSCSA) and other trading partners’ product tracing information should be true, accurate, and complete.

Related Keywords

,Standards For The Interoperable Exchange Of Information ,Cardinal Health ,Mckesson ,Enhanced Drug Distribution Security ,Package Level Under ,Drug Supply Chain Security Act ,Wholesale Distributor Verification Requirement ,Saleable Returned Drug Product ,Illegitimate Product ,Interoperable Exchange ,Certain Human ,Prescription Drugs Guidance ,Smith Drug ,